NIH ends funding of research that uses human fetal tissue from abortions
The National Institutes of Health (NIH) has ceased funding research using human fetal tissue obtained from elective abortions, effective immediately. This reverses a policy implemented by President Biden in 2021 and reinstates a ban initially put in place during the Trump administration.

Briefing Summary
AI-generatedThe National Institutes of Health (NIH) has ceased funding research using human fetal tissue obtained from elective abortions, effective immediately. This reverses a policy implemented by President Biden in 2021 and reinstates a ban initially put in place during the Trump administration. The NIH director stated the decision aims to modernize the agency by investing in alternative technologies for modeling human health and disease. While research using fetal tissue from miscarriages is still permitted, scientists often prefer tissue from elective abortions due to its higher quality and availability. In fiscal year 2024, the NIH directed almost $60 million to 77 projects involving fetal tissue from abortions, which has been used in research for diseases like diabetes and in the development of vaccines.
Article analysis
Model · rule-basedKey claims
5 extractedThis decision is about advancing science by investing in breakthrough technologies.
Fetal tissue has been used to advance research into a large number of diseases.
In fiscal year 2024, the organization directed almost $60m to 77 projects that involved the tissue.
The ban takes effect immediately.
NIH will no longer fund research that uses human fetal tissue obtained from elective abortions.